BioCatalystWatch
NEUPWorkspace / NEUP / OverviewCompany library
Neuphoria Therapeutics Inc. logo

Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc. (NEUP)

Website

Featured programme · CNA3103

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Partner / License out

MK-4334

α7 nAChR

PreINDP1P2P3FilingApproved
MK-4334

α7 nAChR

PreINDP1P2P3FilingApproved
CNA3103

LGR5

PreINDP1P2P3FilingApproved

History / paused

α7 nAChR

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

NEUP SEC archive